Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Finland Smoke-free Finland 2030 network suggests limits for pouches…
  • France National Tobacco Control Programme 2023-2027 published…
  • World COP10 rescheduled to February 2024…
  • Kuwait National Assembly to discuss GCC heated tobacco tax agreement…
  • Russia Tax Code amendment bill signed by president…
  • New Zealand Health organisations against repeal of Smokefree Environments Act…
  • Czech Republic Nicotine pouch and heated tobacco tax bill signed by president…
  • Italy ADM updates price and tax list for heated tobacco…
  • Canada Government releases 2023 Fall Economic Statement
  • United Kingdom MP asks if there will be a debate on smoking and vaping bill…
  • Greece Public consultation on tax bill ends today…
  • Ireland Public consultation launched over tobacco regulation…
View all
News analysis

FDA rejects snus as modified risk – but could reconsider some aspects

Written by || 14th December 2016 || News analysis | Snus | North America United States

Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Court of Justice rejects Swedish Match bid to overturn European snus ban
FDA approves its first modified risk tobacco order for eight snus products
How Swedish Match snus finally got its FDA modified risk approval

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy. 

    © 2023 Tamarind Media Limited (T/A TobaccoIntelligence)

    TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence, does not accept any liability or responsibility for information or views published.